NCT01362062 Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Participants With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Non-Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) and/or Anti-tumor Necrosis Factor (Anti-TNF) Therapy Status COMPLETED Phase N/A
NCT01331837 A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors Status COMPLETED Phase PHASE4
NCT01256736 To Evaluate 1 Year Extension Study of the Efficacy and Safety of Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01245452 Study of the Response and Cardiorespiratory Endurance in Early RA Patients Treated With Tocilizumab or Methotrexate Status COMPLETED Phase NA
NCT01211834 Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01209702 A Study of RoActemra/Actemra (Tocilizumab) in Patients With Ankylosing Spondylitis Who Have Failed Treatment With NSAIDs Status TERMINATED Phase PHASE3
NCT01209689 A Study of Tocilizumab (RoActemra/Actemra) in Patients With Ankylosing Spondylitis Who Have Had an Inadequate Response to Previous Tumor Necrosis Factor (TNF) Antagonist Therapy Status TERMINATED Phase PHASE3
NCT01163747 A Study of the Effects of RoActemra/Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA) Status COMPLETED Phase PHASE4
NCT01120366 Success of Tocilizumab in RA Patients With Remission Induction and Sustained Efficacy After Discontinuation Status COMPLETED Phase PHASE4
NCT01119859 A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE4
NCT01044498 A Study of Tocilizumab in Combination With an Oral Contraceptive in Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01041248 Single Patient Study to Treat Relapsing Polychondritis With Tocilizumab Status COMPLETED Phase NA
NCT01007435 A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00996606 A Study of Tocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDs Status COMPLETED Phase PHASE3
NCT00988221 A Study of Tocilizumab in Patients With Active Polyarticular Juvenile Idiopathic Arthritis Status COMPLETED Phase PHASE3
NCT00868751 Single Patient Use of Tocilizumab in Systemic Onset Juvenile Idiopathic Arthritis Status TERMINATED Phase NA